{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T19:54:31Z","timestamp":1791057271757,"version":"4.1.0"},"reference-count":108,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000266","name":"Engineering and Physical Sciences Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Biotechnology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.tibtech.2026.09.010","type":"journal-article","created":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T12:43:53Z","timestamp":1790945033000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Engineering phage therapeutics with intrinsic biocontainment"],"prefix":"10.1016","author":[{"given":"Maisie R.","family":"Czernuszka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan A.","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Brockhurst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1663-2865","authenticated-orcid":false,"given":"Yizhi","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tibtech.2026.09.010_bb0005","article-title":"Bacteriophages presence in nature and their role in the natural selection of bacterial populations","volume":"91","author":"Naureen","year":"2020","journal-title":"Acta Biomed"},{"key":"10.1016\/j.tibtech.2026.09.010_bb0010","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1057\/s41599-020-0478-4","article-title":"Phage therapy as a potential solution in the fight against AMR: obstacles and possible futures","volume":"6","author":"Brives","year":"2020","journal-title":"Palgrave Commun."},{"key":"10.1016\/j.tibtech.2026.09.010_bb0015","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1250848","article-title":"Regulations of phage therapy across the world","volume":"14","author":"Yang","year":"2023","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.tibtech.2026.09.010_bb0020","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.3390\/v15041020","article-title":"Current clinical landscape and global potential of bacteriophage therapy","volume":"15","author":"Hitchcock","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.tibtech.2026.09.010_bb0025","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1038\/s41564-024-01705-x","article-title":"Personalized bacteriophage therapy outcomes for 100 consecutive cases: a multicentre, multinational, retrospective observational study","volume":"9","author":"Pirnay","year":"2024","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.tibtech.2026.09.010_bb0030","doi-asserted-by":"crossref","first-page":"e208","DOI":"10.1016\/S1473-3099(21)00612-5","article-title":"Safety and efficacy of phage therapy in difficult-to-treat infections: a systematic review","volume":"22","author":"Uyttebroek","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.tibtech.2026.09.010_bb0035","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.3390\/antibiotics11101340","article-title":"The safety and efficacy of phage therapy: a systematic review of clinical and safety trials","volume":"11","author":"Stacey","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.tibtech.2026.09.010_bb0040","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.bcp.2016.12.005","article-title":"Antibiotic resistance: a current epilogue","volume":"134","author":"Dodds","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tibtech.2026.09.010_bb0045","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","author":"Murray","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.tibtech.2026.09.010_bb0050","series-title":"Regulatory Considerations for Therapeutic Use of Bacteriophages in the UK","author":"Medicines & Healthcare products Regulatory Agency","year":"2025"},{"key":"10.1016\/j.tibtech.2026.09.010_bb0055","series-title":"Tackling Antimicrobial Resistance 2019\u20132024","author":"Department of Health and Social Care","year":"2019"},{"key":"10.1016\/j.tibtech.2026.09.010_bb0060","series-title":"The Antimicrobial Potential of Bacteriophages","author":"House of Commons Science, Innovation and Technology Committee","year":"2023"},{"key":"10.1016\/j.tibtech.2026.09.010_bb0065","series-title":"Guideline on Quality Aspects of Phage Therapy Medicinal Products","author":"European Medicines Agency (EMA)","year":"2025"},{"key":"10.1016\/j.tibtech.2026.09.010_bb0070","series-title":"Guidance Document for the Regulatory Framework for the Microorganism Group: Bacteriophages","author":"OECD","year":"2022"},{"key":"10.1016\/j.tibtech.2026.09.010_bb0075","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2025.1631359","article-title":"Regulation of phage therapy medicinal products: developments, challenges, and opportunities","volume":"15","author":"Fuerst-Wilmes","year":"2025","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.tibtech.2026.09.010_bb0080","doi-asserted-by":"crossref","DOI":"10.1128\/cmr.00044-24","article-title":"Pharmacokinetics and pharmacodynamics of bacteriophage therapy: a review with a focus on multidrug-resistant Gram-negative bacterial infections","volume":"37","author":"Siopi","year":"2024","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.tibtech.2026.09.010_bb0085","doi-asserted-by":"crossref","first-page":"721","DOI":"10.3390\/v15030721","article-title":"The future of clinical phage therapy in the United Kingdom","volume":"15","author":"Jones","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.tibtech.2026.09.010_bb0090","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2024.0080","article-title":"Bacteria\u2013phage infection network structure and genomic defence system content predict efficacy of a phage therapy cocktail against Pseudomonas aeruginosa from chronic lung infections","volume":"380","author":"Czernuszka","year":"2025","journal-title":"Phil. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.tibtech.2026.09.010_bb0095","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-64608-3","article-title":"Considerations and perspectives on phage therapy from the transatlantic taskforce on antimicrobial resistance","volume":"16","author":"Moon","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tibtech.2026.09.010_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2025.199537","article-title":"Bridging the gap: phage manufacturing processes from laboratory to agri-food industry","volume":"353","author":"Mohammadi","year":"2025","journal-title":"Virus Res."},{"key":"10.1016\/j.tibtech.2026.09.010_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3002416","article-title":"Systematic and scalable genome-wide essentiality mapping to identify nonessential genes in phages","volume":"21","author":"Piya","year":"2023","journal-title":"PLoS Biol."},{"key":"10.1016\/j.tibtech.2026.09.010_bb0110","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/femsre\/fuaa017","article-title":"Current challenges and future opportunities of phage therapy","volume":"44","author":"Pires","year":"2020","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.tibtech.2026.09.010_bb0115","doi-asserted-by":"crossref","DOI":"10.1111\/mec.70052","article-title":"A phylogenetic host-range index reveals ecological constraints in phage specialisation and virulence","volume":"34","author":"Torres-Barcel\u00f3","year":"2025","journal-title":"Mol. Ecol."},{"key":"10.1016\/j.tibtech.2026.09.010_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/S2666-5247(23)00043-5","article-title":"The unregulated potential of phages","volume":"4","author":"The Lancet Microbe","year":"2023","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.tibtech.2026.09.010_bb0125","series-title":"Phage Therapy: A Practical Approach","first-page":"363","article-title":"Phage therapy in Europe: regulatory and intellectual property protection issues","author":"De Vos","year":"2019"},{"key":"10.1016\/j.tibtech.2026.09.010_bb0130","doi-asserted-by":"crossref","first-page":"60","DOI":"10.36922\/mi.4758","article-title":"The patentability of natural phages as therapeutics in the United States","volume":"2","author":"Yang","year":"2024","journal-title":"Microbes Immun."},{"key":"10.1016\/j.tibtech.2026.09.010_bb0135","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.cels.2015.08.013","article-title":"Engineering modular viral scaffolds for targeted bacterial population editing","volume":"1","author":"Ando","year":"2015","journal-title":"Cell Syst."},{"key":"10.1016\/j.tibtech.2026.09.010_bb0140","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/s41591-019-0437-z","article-title":"Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus","volume":"25","author":"Dedrick","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.tibtech.2026.09.010_bb0145","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2206739119","article-title":"Synthetic engineering and biological containment of bacteriophages","volume":"119","author":"Mitsunaka","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tibtech.2026.09.010_bb0150","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1038\/s41598-021-81580-2","article-title":"Designing P. aeruginosa synthetic phages with reduced genomes","volume":"11","author":"Pires","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tibtech.2026.09.010_bb0155","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.tim.2018.09.006","article-title":"Engineering bacteriophages as versatile biologics","volume":"27","author":"Kilcher","year":"2019","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.tibtech.2026.09.010_bb0160","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1038\/s41587-024-02493-9","article-title":"Leveraging machine learning and big data techniques to map the global patent landscape of phage therapy","volume":"42","author":"Mbogning Fonkou","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.tibtech.2026.09.010_bb0165","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01602-22","article-title":"Engineered bacteriophages containing anti-CRISPR suppress infection of antibiotic-resistant P. aeruginosa","volume":"10","author":"Qin","year":"2022","journal-title":"Microbiol. Spectrum"},{"key":"10.1016\/j.tibtech.2026.09.010_bb0170","doi-asserted-by":"crossref","DOI":"10.1099\/mic.0.001613","article-title":"Interpretation guidance for MHRA regulatory considerations for phage therapeutic products","volume":"171","author":"Coxon","year":"2025","journal-title":"Microbiology (Reading)"},{"key":"10.1016\/j.tibtech.2026.09.010_bb0175","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/s41467-024-44988-8","article-title":"Engineering stringent genetic biocontainment of yeast with a protein stability switch","volume":"15","author":"Hoffmann","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tibtech.2026.09.010_bb0180","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s00705-024-06170-9","article-title":"Designing a simple and efficient phage biocontainment system using the amber suppressor initiator tRNA","volume":"169","author":"Tsoumbris","year":"2024","journal-title":"Arch. Virol."},{"key":"10.1016\/j.tibtech.2026.09.010_bb0185","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.coviro.2011.06.009","article-title":"Bacteriophages and their genomes","volume":"1","author":"Hatfull","year":"2011","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.tibtech.2026.09.010_bb0190","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1751-7915.2011.00292.x","article-title":"Bacteriophage recombineering in the lytic state using the lambda red recombinases","volume":"5","author":"Feh\u00e9r","year":"2012","journal-title":"Microb. Biotechnol."},{"key":"10.1016\/j.tibtech.2026.09.010_bb0195","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1574-6968.2009.01588.x","article-title":"Site-specific recombination of T2 phage using IP008 long tail fiber genes provides a targeted method for expanding host range while retaining lytic activity","volume":"295","author":"Mahichi","year":"2009","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.tibtech.2026.09.010_bb0200","doi-asserted-by":"crossref","first-page":"15440","DOI":"10.1073\/pnas.2237126100","article-title":"Generating a synthetic genome by whole genome assembly: \u03c6X174 bacteriophage from synthetic oligonucleotides","volume":"100","author":"Smith","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tibtech.2026.09.010_bb0205","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4161\/bact.18778","article-title":"Recombineering","volume":"2","author":"Marinelli","year":"2012","journal-title":"Bacteriophage"},{"key":"10.1016\/j.tibtech.2026.09.010_bb0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003957","article-title":"BRED: a simple and powerful tool for constructing mutant and recombinant bacteriophage genomes","volume":"3","author":"Marinelli","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.tibtech.2026.09.010_bb0215","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/s41587-024-02370-5","article-title":"Continuous multiplexed phage genome editing using recombitrons","volume":"43","author":"Fishman","year":"2025","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.tibtech.2026.09.010_bb0220","doi-asserted-by":"crossref","DOI":"10.1038\/s41587-026-03076-6","article-title":"Genome editing of phylogenetically distinct bacteria using cross-species retron-mediated recombineering","author":"Gonz\u00e1lez-Delgado","year":"2026","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.tibtech.2026.09.010_bb0225","doi-asserted-by":"crossref","first-page":"42","DOI":"10.4161\/rna.27766","article-title":"Efficient engineering of a bacteriophage genome using the type I-E CRISPR-Cas system","volume":"11","author":"Kiro","year":"2014","journal-title":"RNA Biol."},{"key":"10.1016\/j.tibtech.2026.09.010_bb0230","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-75426-6","article-title":"Optimization of T4 phage engineering via CRISPR\/Cas9","volume":"10","author":"Duong","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tibtech.2026.09.010_bb0235","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.virol.2012.09.020","article-title":"A fully decompressed synthetic bacteriophage \u00f8X174 genome assembled and archived in yeast","volume":"434","author":"Jaschke","year":"2012","journal-title":"Virology"},{"key":"10.1016\/j.tibtech.2026.09.010_bb0240","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.02897-23","article-title":"A synthetic biology approach to assemble and reboot clinically relevant Pseudomonas aeruginosa tailed phages","volume":"12","author":"Ipoutcha","year":"2024","journal-title":"Microbiol. Spectrum"},{"key":"10.1016\/j.tibtech.2026.09.010_bb0245","article-title":"Cell-free synthesis of infective phages from in vitro assembled phage genomes for efficient phage engineering and production of large phage libraries","volume":"9","author":"Kristensen","year":"2024","journal-title":"Synth. Biol. (Oxf.)"},{"key":"10.1016\/j.tibtech.2026.09.010_bb0250","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1093\/nar\/gkz1240","article-title":"Good guide, bad guide: spacer sequence-dependent cleavage efficiency of Cas12a","volume":"48","author":"Creutzburg","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.tibtech.2026.09.010_bb0255","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/s41467-024-45068-7","article-title":"Structure-guided discovery of anti-CRISPR and anti-phage defense proteins","volume":"15","author":"Duan","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tibtech.2026.09.010_bb0260","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10381","article-title":"Phage engineering and phage-assisted CRISPR-Cas delivery to combat multidrug-resistant pathogens","volume":"8","author":"Khambhati","year":"2023","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.tibtech.2026.09.010_bb0265","article-title":"Generative design of novel bacteriophages with genome language models","author":"King","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.tibtech.2026.09.010_bb0270","doi-asserted-by":"crossref","DOI":"10.1038\/msb4100025","article-title":"Refactoring bacteriophage T7","volume":"1","author":"Chan","year":"2005","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.tibtech.2026.09.010_bb0275","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.chembiol.2022.06.003","article-title":"Cell-free production of personalized therapeutic phages targeting multidrug-resistant bacteria","volume":"29","author":"Emslander","year":"2022","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.tibtech.2026.09.010_bb0280","doi-asserted-by":"crossref","first-page":"11197","DOI":"10.1073\/pnas.0704624104","article-title":"Dispersing biofilms with engineered enzymatic bacteriophage","volume":"104","author":"Lu","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tibtech.2026.09.010_bb0285","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.tibtech.2018.03.008","article-title":"Mastering complexity: towards bottom-up construction of multifunctional eukaryotic synthetic cells","volume":"36","author":"G\u00f6pfrich","year":"2018","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.tibtech.2026.09.010_bb0290","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1146\/annurev-virology-092917-043544","article-title":"Phage-based applications in synthetic biology","volume":"5","author":"Lemire","year":"2018","journal-title":"Annu. Rev. Virol."},{"key":"10.1016\/j.tibtech.2026.09.010_bb0295","series-title":"Synthetic DNA: Methods and Protocols","first-page":"187","article-title":"Efficient assembly of DNA using yeast homologous recombination (YHR)","author":"Chandran","year":"2017"},{"key":"10.1016\/j.tibtech.2026.09.010_bb0300","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1021\/acssynbio.9b00411","article-title":"Saturation mutagenesis genome engineering of infective \u03a6X174 bacteriophage via unamplified oligo pools and Golden Gate assembly","volume":"9","author":"Faber","year":"2020","journal-title":"ACS Synth. Biol."},{"key":"10.1016\/j.tibtech.2026.09.010_bb0305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145682","article-title":"Rational design of high-number dsDNA fragments based on thermodynamics for the construction of full-length genes in a single reaction","volume":"10","author":"Birla","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.tibtech.2026.09.010_bb0310","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkae809","article-title":"Enhanced Golden Gate Assembly: evaluating overhang strength for improved ligation efficiency","volume":"52","author":"Strzelecki","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.tibtech.2026.09.010_bb0315","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1073\/pnas.1714658115","article-title":"Cross-genus rebooting of custom-made, synthetic bacteriophage genomes in L-form bacteria","volume":"115","author":"Kilcher","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tibtech.2026.09.010_bb0320","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1038\/s41467-024-46585-1","article-title":"PHEIGES: all-cell-free phage synthesis and selection from engineered genomes","volume":"15","author":"Levrier","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tibtech.2026.09.010_bb0325","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1007\/s00253-009-2349-1","article-title":"Methodologies to increase the transformation efficiencies and the range of bacteria that can be transformed","volume":"85","author":"Aune","year":"2010","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.tibtech.2026.09.010_bb0330","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1021\/acssynbio.2c00244","article-title":"SpyPhage: a cell-free TXTL platform for rapid engineering of targeted phage therapies","volume":"11","author":"Liyanagedera","year":"2022","journal-title":"ACS Synth. Biol."},{"key":"10.1016\/j.tibtech.2026.09.010_bb0335","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1021\/acssynbio.3c00239","article-title":"Cell free bacteriophage synthesis from engineered strains improves yield","volume":"12","author":"Brooks","year":"2023","journal-title":"ACS Synth. Biol."},{"key":"10.1016\/j.tibtech.2026.09.010_bb0340","article-title":"The all-E. coli TXTL toolbox 3.0: new capabilities of a cell-free synthetic biology platform","volume":"6","author":"Garenne","year":"2021","journal-title":"Synth. Biol. (Oxf.)"},{"key":"10.1016\/j.tibtech.2026.09.010_bb0345","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12934-025-02661-9","article-title":"Cell-free expression system: a promising platform for bacteriophage production and engineering","volume":"24","author":"Nour El-Din","year":"2025","journal-title":"Microb. Cell Factories"},{"key":"10.1016\/j.tibtech.2026.09.010_bb0350","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3390\/v17010045","article-title":"Synthesis of headful packaging phages through yeast transformation-associated recombination","volume":"17","author":"Lu","year":"2025","journal-title":"Viruses"},{"key":"10.1016\/j.tibtech.2026.09.010_bb0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2025.104012","article-title":"Protocol for end-design-free rebooting of terminally redundant Pseudomonas phages in clinical isolates of Pseudomonas aeruginosa","volume":"6","author":"Yokoyama","year":"2025","journal-title":"STAR Protoc."},{"key":"10.1016\/j.tibtech.2026.09.010_bb0360","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/s41589-018-0056-x","article-title":"Next-generation biocontainment systems for engineered organisms","volume":"14","author":"Lee","year":"2018","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.tibtech.2026.09.010_bb0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.106165","article-title":"Safety by design: biosafety and biosecurity in the age of synthetic genomics","volume":"26","author":"Hoffmann","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.tibtech.2026.09.010_bb0370","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nature14121","article-title":"Biocontainment of genetically modified organisms by synthetic protein design","volume":"518","author":"Mandell","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.tibtech.2026.09.010_bb0375","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nature14095","article-title":"Recoded organisms engineered to depend on synthetic amino acids","volume":"518","author":"Rovner","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.tibtech.2026.09.010_bb0380","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1038\/s41467-024-45893-w","article-title":"Cas9-assisted biological containment of a genetically engineered human commensal bacterium and genetic elements","volume":"15","author":"Hayashi","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tibtech.2026.09.010_bb0385","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/1574-6976.12072","article-title":"Bacteria\u2013phage coevolution as a driver of ecological and evolutionary processes in microbial communities","volume":"38","author":"Koskella","year":"2014","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.tibtech.2026.09.010_bb0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2025.107614","article-title":"Cross-border dialogue: an international survey of regulators on phage therapy","volume":"66","author":"Alvarez","year":"2025","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.tibtech.2026.09.010_bb0395","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-065401","article-title":"Standardised treatment and monitoring protocol to assess safety and tolerability of bacteriophage therapy for adult and paediatric patients (STAMP study): protocol for an open-label, single-arm trial","volume":"12","author":"Khatami","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.tibtech.2026.09.010_bb0400","article-title":"Phage therapy: eco-physiological pharmacology","volume":"2014","author":"Abedon","year":"2014","journal-title":"Scientifica (Cairo)"},{"key":"10.1016\/j.tibtech.2026.09.010_bb0405","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s44259-024-00045-4","article-title":"Phage therapy could be key to conquering persistent bacterial lung infections in children","volume":"2","author":"Sithu Shein","year":"2024","journal-title":"NPJ Antimicrob. Resist."},{"key":"10.1016\/j.tibtech.2026.09.010_bb0410","doi-asserted-by":"crossref","DOI":"10.1093\/femsre\/fuad038","article-title":"Drivers and consequences of bacteriophage host range","volume":"47","author":"Holtappels","year":"2023","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.tibtech.2026.09.010_bb0415","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1042\/EBC20160013","article-title":"Synthetic biology approaches to biological containment: pre-emptively tackling potential risks","volume":"60","author":"Torres","year":"2016","journal-title":"Essays Biochem."},{"key":"10.1016\/j.tibtech.2026.09.010_bb0420","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1093\/molbev\/msy027","article-title":"Rates of mutation and recombination in Siphoviridae phage genome evolution over three decades","volume":"35","author":"Kupczok","year":"2018","journal-title":"Mol. Biol. Evol."},{"key":"10.1016\/j.tibtech.2026.09.010_bb0425","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3390\/cells13070585","article-title":"Controlling recombination to evolve bacteriophages","volume":"13","author":"Bull","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.tibtech.2026.09.010_bb0430","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.3390\/v17081094","article-title":"Phage therapy: combating evolution of bacterial resistance to phages","volume":"17","author":"Abedon","year":"2025","journal-title":"Viruses"},{"key":"10.1016\/j.tibtech.2026.09.010_bb0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2024.107088","article-title":"Phage therapy: a targeted approach to overcoming antibiotic resistance","volume":"197","author":"Olawade","year":"2024","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.tibtech.2026.09.010_bb0440","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/nchembio.1979","article-title":"\u2018Deadman\u2019 and \u2018passcode\u2019 microbial kill switches for bacterial containment","volume":"12","author":"Chan","year":"2016","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.tibtech.2026.09.010_bb0445","article-title":"The bacteriophage decides own tracks: when they are with or against the bacteria","volume":"2","author":"Makky","year":"2021","journal-title":"Curr. Res. Microb. Sci."},{"key":"10.1016\/j.tibtech.2026.09.010_bb0450","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/v16010008","article-title":"Development of a replication-deficient bacteriophage reporter lacking an essential baseplate wedge subunit","volume":"16","author":"Gil","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.tibtech.2026.09.010_bb0455","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0378-1119(93)90541-A","article-title":"Deletion of the essential gene 24 from the bacteriophage T4 genome","volume":"123","author":"Engman","year":"1993","journal-title":"Gene"},{"key":"10.1016\/j.tibtech.2026.09.010_bb0460","article-title":"Biocontainment of phages inhibits bacterial clearance in micro niches","author":"Boot-Handford","year":"2026","journal-title":"bioRxiv"},{"key":"10.1016\/j.tibtech.2026.09.010_bb0465","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.tibs.2022.08.009","article-title":"Discovering riboswitches: the past and the future","volume":"48","author":"Kavita","year":"2023","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.tibtech.2026.09.010_bb0470","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1042\/BST0330474","article-title":"Engineered riboswitches control gene expression by small molecules","volume":"33","author":"Suess","year":"2005","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.tibtech.2026.09.010_bb0475","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1038\/s41598-024-52049-9","article-title":"T7 phage-assisted evolution of riboswitches using error-prone replication and dual selection","volume":"14","author":"Goicoechea Serrano","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tibtech.2026.09.010_bb0480","doi-asserted-by":"crossref","first-page":"E554","DOI":"10.1073\/pnas.1318563111","article-title":"Artificial riboswitches for gene expression and replication control of DNA and RNA viruses","volume":"111","author":"Ketzer","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tibtech.2026.09.010_bb0485","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1021\/acssynbio.3c00768","article-title":"Degron-controlled protein degradation in Escherichia coli: new approaches and parameters","volume":"13","author":"Cronan","year":"2024","journal-title":"ACS Synth. Biol."},{"key":"10.1016\/j.tibtech.2026.09.010_bb0490","doi-asserted-by":"crossref","DOI":"10.3389\/fsybi.2025.1548572","article-title":"Genetic circuits in synthetic biology: broadening the toolbox of regulatory devices","volume":"3","author":"M\u00fcller","year":"2025","journal-title":"Front. Synth. Biol."},{"key":"10.1016\/j.tibtech.2026.09.010_bb0495","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s13353-016-0341-x","article-title":"Emerging applications of riboswitches \u2013 from antibacterial targets to molecular tools","volume":"57","author":"Machtel","year":"2016","journal-title":"J. Appl. Genet."},{"key":"10.1016\/j.tibtech.2026.09.010_bb0500","doi-asserted-by":"crossref","first-page":"5410","DOI":"10.1093\/nar\/gkw232","article-title":"Exploring the modular nature of riboswitches and RNA thermometers","volume":"44","author":"Ro\u00dfmanith","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.tibtech.2026.09.010_bb0505","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1021\/acssynbio.9b00017","article-title":"Systematic evaluation of genetic and environmental factors affecting performance of translational riboswitches","volume":"8","author":"Kent","year":"2019","journal-title":"ACS Synth. Biol."},{"key":"10.1016\/j.tibtech.2026.09.010_bb0510","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1126\/science.add8943","article-title":"Refactored genetic codes enable bidirectional genetic isolation","volume":"378","author":"Z\u00fcrcher","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.tibtech.2026.09.010_bb0515","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1093\/nar\/gku1378","article-title":"Multilayered genetic safeguards limit growth of microorganisms to defined environments","volume":"43","author":"Gallagher","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.tibtech.2026.09.010_bb0520","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1128\/MMBR.00069-15","article-title":"Genetically engineered phages: a review of advances over the last decade","volume":"80","author":"Pires","year":"2016","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.tibtech.2026.09.010_bb0525","doi-asserted-by":"crossref","DOI":"10.1093\/sumbio\/qvae030","article-title":"Exploring perceptions of bacteriophage use in the UK across the One Health spectrum: a roundtable discussion","volume":"1","author":"Cullen","year":"2024","journal-title":"Sustain. Microbiol."},{"key":"10.1016\/j.tibtech.2026.09.010_bb0530","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0285824","article-title":"Phage therapy and the public: increasing awareness essential to widespread use","volume":"18","author":"McCammon","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.tibtech.2026.09.010_bb0535","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2025.1490737","article-title":"Perception of phage therapy and research across selected professional and social groups in Poland","volume":"13","author":"\u017baczek","year":"2025","journal-title":"Front. Public Health"},{"key":"10.1016\/j.tibtech.2026.09.010_bb0540","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-029134","article-title":"Public awareness, acceptability and risk perception about infectious diseases dual-use research of concern: a cross-sectional survey","volume":"10","author":"MacIntyre","year":"2020","journal-title":"BMJ Open"}],"container-title":["Trends in Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016777992600380X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016777992600380X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T19:38:10Z","timestamp":1791056290000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016777992600380X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":108,"alternative-id":["S016777992600380X"],"URL":"https:\/\/doi.org\/10.1016\/j.tibtech.2026.09.010","relation":{},"ISSN":["0167-7799"],"issn-type":[{"value":"0167-7799","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Engineering phage therapeutics with intrinsic biocontainment","name":"articletitle","label":"Article Title"},{"value":"Trends in Biotechnology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tibtech.2026.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}